ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

ClinicalTrials.gov ID: NCT00099294

Public ClinicalTrials.gov record NCT00099294. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 11:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine

Study identification

NCT ID
NCT00099294
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Threshold Pharmaceuticals
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Glufosfamide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
Dec 31, 2006
Completion
Dec 31, 2006
Last update posted
Apr 29, 2009

2004 – 2007

United States locations

U.S. sites
23
U.S. states
20
U.S. cities
22
Facility City State ZIP Site status
Augusta Oncology Associates Los Angeles California 90057
Kenmar Research Institute Los Angeles California 90057
Mile High Oncology Denver Colorado 80210
Northwestern Connecticut Oncology - Hematology Associates Torrington Connecticut 06790
Palm Beach Institute of Hematology and Oncology Boynton Beach Florida 33435
Hematology/Oncology of the North Shore Skokie Illinois 60076
Fort Wayne Medical Oncology/Hem Fort Wayne Indiana 46815
Norton Healthcare Center Louisville Kentucky 40202
West Michigan Cancer Center Kalamazoo Michigan 49007
Hattiesburg Clinic Oncology Hattiesburg Mississippi 39401
Columbia Comprehensive Cancer Care Clinic Columbia Missouri 65201
Bond Clinic Rolla Missouri 65401
Deaconess Billings Clinic Billings Montana 59101
Office of Clinical Trials Paramus New Jersey 07652
New Mexico Oncology Hematology Consultants Albuquerque New Mexico 87109
Hanover Medical Specialists Wilmington North Carolina 28401
Vita Hematology Oncology PC Bethlehem Pennsylvania 18015
The Family Cancer Center , PLLC Collierville Tennessee 38017
Center for Oncology Research and Treatment Dallas Texas 75230
JPS Center for Cancer Care Fort Worth Texas 76104
Northern Utah Associates Ogden Utah 84403
Cancer Outreach Association Abingdon Virginia 24211
Marshfield Clinic Research Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00099294, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2009 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00099294 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →